Anthony Harrelson of Virginia is the founder and CEO of White Oak Industries, a biopharmaceutical company developing personalized immunotherapies and vaccines for infectious diseases like Ebola and HIV. White Oak recently expanded its R&D efforts to include vaccines to prevent Ebola virus infection. Harrelson says the company's novel DNA platform technology shows promise in treating deadly viruses and could be an important medical breakthrough.

1. Anthony Harrelson of Virginia is
the founder and Chief Executive
Officer of White Oak Industries.
He says that White Oak is a
biopharmaceutical company that
is focused on developing and
commercializingfully personalized
immunotherapies that can be
used in the treatment of
infectious diseases, including
Ebola and HIV.
"We have recently expanded our
research and development efforts
to include vaccines to prevent
Ebola virus infection," says
Anthony Harrelson of Virginia.
Anthony Harrelson of Virginia is
the founder and Chief Executive
Officer of White Oak Industries.
He says that White Oak is a
biopharmaceutical company that
is focused on developing and
commercializingfully personalized
immunotherapies that can be
used in the treatment of
infectious diseases, including
Ebola and HIV.
"We have recently expanded our
research and development efforts
to include vaccines to prevent
Ebola virus infection," says
Anthony Harrelson of Virginia.

2. Anthony Harrelson Virginia is the founder and Chief Executive Officer of White Oak
Industries. He says that White Oak is a clinical-stage biotechnology company that is
developing innovative human vaccines using a novel DNA platform technology.
Its vaccines show great promise in treating such deadly contagious viruses as HIV and
Ebola. It couldn't come at a better time.
Anthony Harrelson Virginia is the founder and Chief Executive Officer of White Oak
Industries. He says that White Oak is a clinical-stage biotechnology company that is
developing innovative human vaccines using a novel DNA platform technology.
Its vaccines show great promise in treating such deadly contagious viruses as HIV and
Ebola. It couldn't come at a better time.
The Ebola outbreak in West
Africa that began more than one
year ago is the largest and most
serious Ebola outbreak since the
virus was first identified nearly
forty years ago. As he knows,
this latest outbreak has resulted
in more new cases, and has
caused more deaths, than all
other preceding Ebola outbreaks
combined.
The Ebola outbreak in West
Africa that began more than one
year ago is the largest and most
serious Ebola outbreak since the
virus was first identified nearly
forty years ago. As he knows,
this latest outbreak has resulted
in more new cases, and has
caused more deaths, than all
other preceding Ebola outbreaks
combined.

3. Anthony Harrelson of Virginia is the founder
and CEO of White Oak Industries. He says
that his company may be sitting on one of
the most important medical breakthroughs
in many years.
"White Oak Industries has positive,
conclusive evidence that our treatment
isolates HIV antigens from patients' plasma,"
Anthony Harrelson of Virginia is the founder
and CEO of White Oak Industries. He says
that his company may be sitting on one of
the most important medical breakthroughs
in many years.
"White Oak Industries has positive,
conclusive evidence that our treatment
isolates HIV antigens from patients' plasma,"
he says. "Our vaccine platform is surpassing conventional vaccine and other
experimental immune-stimulating technologies. There are several huge advantages to
our terminology; there is no toxicity and we are using stem cells that are programmed
to only do good and repair damaged cells.“
He says that in theory, at least, the company's technology would work on anything viral,
including such infectious diseases as the Marburg virus, Ebola, Hantavirus, the H5N1
strain of bird flue, Lassa virus, Junin virus, Dengue fever, Bolivian hemorrhagic fever,
and the Kyasanur Forestirus (KFD) virus – "to which there is no known cure.“
he says. "Our vaccine platform is surpassing conventional vaccine and other
experimental immune-stimulating technologies. There are several huge advantages to
our terminology; there is no toxicity and we are using stem cells that are programmed
to only do good and repair damaged cells.“
He says that in theory, at least, the company's technology would work on anything viral,
including such infectious diseases as the Marburg virus, Ebola, Hantavirus, the H5N1
strain of bird flue, Lassa virus, Junin virus, Dengue fever, Bolivian hemorrhagic fever,
and the Kyasanur Forestirus (KFD) virus – "to which there is no known cure.“

4. Anthony Harrelson of Virginia says that White Oak Industries was formed to develop
promising new vaccine technologies that can be used in the international fight against
the Ebola and HIV viruses.
As he knows, the fight against the 2014 Ebola outbreak of Ebola Virus Disease is far
from over. That outbreak has been concentrated in several West African countries,
but as he knows, there have been several cases reported in the United States.
Anthony Harrelson of Virginia says that White Oak Industries was formed to develop
promising new vaccine technologies that can be used in the international fight against
the Ebola and HIV viruses.
As he knows, the fight against the 2014 Ebola outbreak of Ebola Virus Disease is far
from over. That outbreak has been concentrated in several West African countries,
but as he knows, there have been several cases reported in the United States.

5. http://anthonyharrelsonvirginia.weebly.com/

6. http://anthonyharrelsonvirginia.weebly.com/